Why Your Body Destroys NAD+ Before It Can Use It (And the $5 Fix Nobody Talks About)

Your body cannot absorb NAD+ directly. That is the starting point, and it changes how you need to think about every supplement in this category.

NAD+ is a large molecule, and large molecules cannot pass through cell membranes. So when you take an NAD+ supplement, or get an NAD+ IV infusion, the molecule never actually makes it inside your cells intact. A 2019 study tracking a 750 milligram intravenous NAD+ infusion found that every bit of it was broken down in the bloodstream before any of it reached cells, with the metabolites confirming complete extracellular degradation. The IV delivered NAD+ into your blood, and your blood destroyed it before it could do anything.

That is not a flaw in the process. That is the process.

Your body breaks NAD+ down into smaller pieces so it can ferry those pieces into cells and reassemble them on the inside. The main route for this is something called the salvage pathway, which is essentially a recycling system that takes NAD+ breakdown products, mostly a compound called nicotinamide, and rebuilds them back into NAD+ inside the cell.

NMN and NR supplements both rely on this pathway. NR, which stands for nicotinamide riboside, enters cells directly and feeds into the salvage machinery. NMN, which stands for nicotinamide mononucleotide, cannot even enter cells in its current form and has to be converted to NR first by an enzyme called CD73, which sits on the outside of cells. So whether you are taking NMN or NR, both molecules end up funneling through the same salvage pathway inside the cell. They are different entry points to the same road.

That matters because the salvage pathway has a serious problem as you age.

There is an enzyme called CD38, which functions like a molecular shredder for NAD+. It breaks NAD+ down as part of immune signaling and inflammatory responses, and it becomes dramatically more active as you get older. A 2016 study found that CD38 activity increases two to three fold across tissues with age, and the correlation between rising CD38 and falling NAD+ levels is nearly perfect. The older you get, the faster this enzyme chews through your NAD+ before your cells can use it.

So you are supplementing NMN or NR, sending more precursors through the salvage pathway, and CD38 is sitting at the exit degrading the finished product. You are filling a bucket with a hole in it, and the hole gets bigger every decade.

This is the problem with the way most people frame NAD+ supplementation. The conversation focuses entirely on which precursor to take and at what dose, when the real bottleneck is downstream of the precursor entirely.

But there is a second pathway your body can use to make NAD+ that bypasses the salvage system completely. It is called the Preiss-Handler pathway, and it runs on something you already know: niacin, also called vitamin B3.

Niacin enters through a completely separate set of receptors and gets converted to NAD+ through a different enzymatic chain that does not run through the same congested salvage machinery. It is a second road to the same destination, and CD38 cannot block it at the entry point.

A 2020 study tested this directly in people with confirmed NAD+ deficiency caused by mitochondrial disease. Subjects took niacin at doses ranging from 750 to 1000 milligrams per day. After supplementation, blood NAD+ levels rose 2.3 times. Muscle NAD+ rose 1.3 times. Muscle strength improved. Markers of mitochondrial biogenesis increased. That increase in blood NAD+ is in the same range as what studies report for NMN and NR, and niacin costs about five dollars a month at any pharmacy.

There is a catch worth understanding. Niacin at these doses causes something called a niacin flush, which is a temporary reddening and tingling of the skin that happens when niacin triggers prostaglandin release in skin cells. It feels strange the first time, and some people find it uncomfortable, but it is not harmful and it fades over one to two weeks of consistent use as your body adapts. Starting at a lower dose and building up slowly reduces how intense it is.

There is also something interesting happening with NR that connects these two pathways. A 2019 study in older adults found that NR supplementation raised levels of a compound called NAAD, which is an intermediate in the Preiss-Handler pathway, inside human muscle. This suggests that some portion of NR actually converts to nicotinic acid in the body and ends up traveling through the Preiss-Handler pathway anyway, not just the salvage pathway it is supposed to use. The cleaner and more direct way to use the Preiss-Handler pathway is just to use niacin directly.

None of this means NMN and NR are useless. The salvage pathway still works, just less efficiently with age, and there are people who tolerate NR and NMN well and see real results. But the framing that you need an expensive, cutting-edge precursor to support NAD+ levels ignores that a cheap, well-studied vitamin takes a completely different road to the same place.

The supplement industry benefits from the complexity here. Every new molecular variant of the same basic concept gets presented as a breakthrough, and the pricing reflects that framing rather than the underlying biochemistry. But the underlying biochemistry is pointing toward niacin as the more direct solution for most people.

Your body has been using the Preiss-Handler pathway since long before anyone was selling NMN capsules for sixty dollars a month. The enzyme that runs on niacin does not get more congested with age the way the salvage pathway does. And the evidence for what niacin actually does to NAD+ levels in deficient human tissue is about as direct as any study in this space.

The expensive version of this problem and the cheap version of this problem have the same answer. That is worth sitting with.

---

References

1. Ratajczak J, Joffraud M, Trammell SAJ, et al. 2016. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells. Nature Communications, 7:13103. Finding: NMN must be converted to NR by CD73 before cellular uptake, establishing NR as the common entry point for both NMN and NR supplementation. Source
2. Elhassan YS, Kluckova K, Fletcher RS, et al. 2019. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports, 287:1717-1728. Finding: NR supplementation produced significant increases in NAAD a Preiss-Handler pathway intermediate in human muscle, indicating NR partially converts to nicotinic acid in vivo. Source
3. Pirinen E, Auranen M, Khan NA, et al. 2020. Niacin cures systemic NAD+ deficiency and improves muscle performance in adult-onset mitochondrial myopathy. Cell Metabolism, 316:1078-1090. Finding: Niacin 750-1000 mg/day raised blood NAD+ 2.3x and muscle NAD+ 1.3x in human subjects via the Preiss-Handler pathway, with concurrent improvements in muscle strength and mitochondrial biogenesis. Source
4. Grant R, Berg J, Mestayer R, et al. 2019. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6 hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience, 11:257. Finding: IV NAD+ 750 mg was rapidly and completely removed from plasma, with metabolites confirming full extracellular degradation before cellular uptake. Source
5. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. 2016. CD38 dictates age-related NAD decline and mitochondrial dysfunction through an SIRT3-dependent mechanism. Cell Metabolism, 236:1127-1139. Finding: CD38 activity increases 2-3 fold with age across tissues, with near-perfect inverse correlation to NAD+ levels. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness